In this context, exploring the mechanistic relationship between GLP-1 receptor activation and mitochondrial function in the brain may provide valuable insights into novel therapeutic strategies for AD (Liang et al., 2024)
Intimately familiar with the amino acid structure of glucagon, Mojsov had a hunch that the active part of GLP-1 might in fact be located in a small stretch of the peptide
Thus, enhanced CYP2E1 did not differentiate bland steatosis from NASH, but could still play a role in disease progression
Some healthcare professionals may recommend the combination because of theoretical considerations
Rather than targeting more receptors with a single molecule, it combines two separate compounds, cagrilintide (an amylin analogue) and semaglutide (a GLP-1 agonist), into a single weekly injection
Saxenda, Wegovy and Zepbound are all GLP-1 receptor agonists that work by stimulating the GLP-1 receptor in the brain to help people feel full